Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events ...
Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果